NeuroSAE: May 2023
Course Description
- Written by neurologists for neurologists.
- Questions based on the ABPN content outline for the cognitive expertise component (Part III) of Continuing Certification (CC).
- Assess your areas of strengths and weaknesses.
- Compare your performance to other neurologists.
- Up to 20 percent of questions with images.
- Convenient online format: take on your own time, at your own pace.
- Offers opportunity to earn 2 self-assessment credits of CME per exam.
- Fulfill both the self-assessment component and the CME component of your Continuing Certification (CC).
- The AAN has a minimum performance pass rate of 70 percent in order to comply with the AMA PRA Category 1 Credit™ requirements.
- Participants can retake the test if they do not pass the first time.
Core Competencies
- Medical Knowledge
Learning Objectives
As a result of this self-assessment activity, the learner will be able to:- Identify major clinical areas of neurology that require more focused study and review.
- Evaluate areas of strength and weakness and consult educational resources for self-education and improvement.
- Apply new and reviewed information derived from the exam and resources into clinical practice to provide optimal patient care..
Date of Release
Date of Release: May 10, 2023.Duration Statement: This exam is eligible for 2 self assessment CME credits for three years from the release date
Confidentiality of Data
All material © American Academy of Neurology Institute unless otherwise indicated. All rights reserved. See complete
Terms of Use.
The American Academy of Neurology (AAN) is not requesting any individually identifiable information. The data you submit to the AAN through the NeuroSAE® is de-identified, as it neither identifies nor provides a reasonable basis to identify an individual. All information submitted to the AAN through NeuroSAE® is confidential. Data may be used and presented anonymously and in aggregate by the AAN.
The American Academy of Neurology (AAN) is not requesting any individually identifiable information. The data you submit to the AAN through the NeuroSAE® is de-identified, as it neither identifies nor provides a reasonable basis to identify an individual. All information submitted to the AAN through NeuroSAE® is confidential. Data may be used and presented anonymously and in aggregate by the AAN.
Content Outline
|
|
ACCREDITATION
The American Academy of Neurology Institute (AANI), a subsidiary of the American Academy of Neurology (AAN), is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA CREDIT DESIGNATION STATEMENT
The American Academy of Neurology Institute (AANI) designates this enduring material for a maximum of 2
AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ROYAL COLLEGE OF PHYSICIANS AND SURGEONS OF CANADA CREDIT DESIGNATION STATEMENT
The NeuroSAE program is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by the University of Calgary Office of Continuing Medical Education and Professional Development. Program expires August 4, 2026. Remember to visit MAINPORT to record your learning and outcomes. Canadian participants may claim a maximum of 2 hours (credits are automatically calculated). Participants cannot claim credit for issues prior to July 2017.
ABPN APPROVED ACTIVITYThe American Board of Psychiatry and Neurology (ABPN) has reviewed and approved this program for CME and as part of a Self-Assessment program, which is mandated by the American Board of Medical Specialties (ABMS) as a necessary component of Continuing Certification (CC).
FACULTY & DISCLOSURESNote: All relevant financial relationships have been mitigated.Patrick Landazuri, MD Chair Neurology Specialist University of Kansas Medical Center Kansas City, KS *Dr. Landazuri has nothing to disclose. Hossein Ansari, MD, FAAN Director of Headache and Facial Pain Clinic Kaizen Brain Center, La Jolla, CA Associate Professor of Neurology University of California, San Diego San Diego, CA *Dr. Ansari has received personal compensation for serving as a Consultant for NOEMA Pharmaceutical. Dr. Ansari has received personal compensation for serving as a Consultant for BIOHAVEN Pharmaceutical. Dr. Ansari has received personal compensation for serving as a Consultant for BioDelivery Sciences International, Inc. . Dr. Ansari has received personal compensation for serving on a Speakers Bureau for AbbVie Pharmaceutical. Dr. Ansari has received personal compensation for serving on a Speakers Bureau for Amgen Pharmaceutical. Dr. Ansari has received personal compensation for serving on a Speakers Bureau for Biohaven Pharmaceutical. Dr. Ansari has received personal compensation for serving on a Speakers Bureau for Eli Lilly and Company. Dr. Ansari has received personal compensation for serving on a Speakers Bureau for Lundbeck Pharmaceutical. Dr. Ansari has received personal compensation in for serving on a Speakers Bureau for Teva Pharmaceutical. Dr. Ansari has received personal compensation for serving as an Expert Witness for MedLegal Network. Dr. Ansari has received personal compensation for serving as an Expert Witness for Litogation Legal insight ( LITILI). Dr. Ansari has received personal compensation for serving as an Expert Witness for FOLAND, WICKENS, ROPER, HOFER & CRAWFORD, P.C. Sherri Braksick, MD Neurointensivist Mayo Clinic Rochester, MN *Dr. Braksick has nothing to disclose. Erin E. Carlson, MD Health Partners Stillwater, MN *Dr. Carlson has nothing to disclose. William Cheshire, MD, FAAN Professor of Neurology, Mayo Clinic Jacksonville, Florida *Dr. Cheshire has received personal compensation for serving as a Consultant for Oxford University Press. Dr. Cheshire has received personal compensation for serving as a Consultant for Elsevier. Dr. Cheshire has received research support from Biohaven. Dr. Cheshire has received personal compensation for serving as a Visiting professor with Trinity International University. Dr. Cheshire has a non-compensated relationship as a Board of Directors with the American Autonomic Society that is relevant to AAN interests or activities. Dr. Cheshire has a non-compensated relationship as an Associate Editor with Clinical Autonomic Research that is relevant to AAN interests or activities. Colin Culbertson,MD Lahey Hospital & Medical Center Burlington, MA Dr. Culbertson has nothing to disclose. Andres F. Deik, MD, MSEd Assistant Professor of Clinical Neurology University of Pennsylvania Philadelphia, PA *Dr. Deik Acosta Madiedo has received personal compensation for serving as a Consultant for Amneal Pharmaceuticals. Dr. Deik Acosta Madiedo has received personal compensation for serving on a Scientific Advisory or Data Safety Monitoring board for Acorda Therapeutics. The institution of Dr. Deik Acosta Madiedo has received research support from Sunovion Pharmaceuticals, Revance Therapeutics, Insightec, Teva Pharmaceuticals, Cerevel Therapeutics, and Prevail Therapeutics. Dr. Deik Acosta Madiedo has received publishing royalties from a publication relating to health care. Tirisham Gyang, MDAssistant Professor of Neurology Ohio State University Columbus, OH *Dr. Gyang has received personal compensation for consultation with Genentech, Greenwich Biosciences, Horizon Therapeutics and EMD Serono.Dr. Gyang has received personal compensation for serving as a Consultant for Greenwich Biosciences. Dr. Gyang has received personal compensation for serving as a Consultant for Horizon Therapeutics. Tamara Kaplan, MD Assistant Professor Neurology Brigham and Women's Hospital Boston, MA *Dr. Kaplan has received personal compensation for serving as a Consultant for Novartis, Genentech, Bristol Myers Squibb, and Biogen. Jessica Doyle Lee, MD, FAAN, FANA Vascular Neurology Fellowship Director Associate Professor of Neurology University of Kentucky College of Medicine Lexington, KY *Dr. Lee has received personal compensation for serving as an employee of Christiana Care Hospital and the American Academy of Neurology. Lili Velickovic Ostojic, MD Assistant Professor of Neurology Ichan School of Medicine at Mount Sinai New York, NY *Dr. Ostojic has nothing to disclose. Bhavana Patel, DO Assistant Professor of Neurology University of Florida Gainesville, FL *Dr. Patel has nothing to disclose. Swetha Renati, MD University of South Florida Tampa, FL *Dr. Renati has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FirstKind Ltd. Dr. Renati has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PRIME EDUCATION. Dr. Renati has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Wettermark Keith, LLC. Dr. Renati has received personal compensation in the range of $500-$4,999 for serving as a Speaker with BRAINWEEK. Maisha T. Robinson, MD, MSHPM, FAAN Assistant Professor Department of Neurology Mayo Clinic Jacksonville,FL>br> *The institution of Dr. Robinson has received research support from Florida Department of Health. The institution of Dr. Robinson has received research support from Community Foundation. Dr. Robinson has received publishing royalties from a publication relating to health care. Dr. Robinson has received personal compensation in the range of $5,000-$9,999 for serving as a Longitudinal Knowledge Assessment committee on hospice and palliative care member with American Board of Internal Medicine. Dr. Robinson has a non-compensated relationship as a President-Elect with International Neuropalliative Care Society that is relevant to AAN interests or activities. Harini Sarva, MD Professor of Clinical Neurology Weill Cornell Medical Center New York, NY Dr. Sarva has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Sarva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Sarva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bluerock Therapeutics. The institution of Dr. Sarva has received research support from Insightec. The institution of Dr. Sarva has received research support from NeuroNext. The institution of Dr. Sarva has received research support from Neuroderm. The institution of Dr. Sarva has received research support from Covance. The institution of Dr. Sarva has received research support from Prevail. The institution of Dr. Sarva has received research support from Bluerock Therapeutics. The institution of Dr. Sarva has received research support from Biogen. The institution of Dr. Sarva has received research support from Roche. HyungSub Shim, MD Clinical Assistant Professor, Neurology & Psychiatry University of Iowa Iowa City, IA *Dr. Shim has nothing to disclose. Sheetal Shroff, MD Neurologist Houston Methodist Hospital Houston, TX *Dr. Shroff has received personal compensation from Alnylam. Uzma Usman, MBBS Assistant Professor Yale School of Medicine New Haven, CT *Dr. Usman has nothing to disclose. Jayashree Sundararajan, MD Cleveland Clinic Neurological Institute Cleveland, OH *Dr. Sundararajan has nothing to disclose. Emerlee Helen Timmerman, MD Assistant Professor Behavioral Neurology University of Cincinatti Cincinatti, OH *Dr. Timmerman has nothing to disclose. Utku Uysal, MD Assistant Professor of Neurology Kansas University Kansas City, KS *Dr. Uysal has nothing to disclose. NEUROSAE STAFFXiaoyu Sun, Associate Director, eLearningMinneapolis, MN *Ms. Sun has nothing to disclose. Lynne Shindoll, MA, Manager, eLearning Minneapolis, MN *Ms. Shindoll has nothing to disclose. Tessa Dahlgren,eLearning Production Program Manager Minneapolis, MN *Ms. Dahlgren has nothing to disclose. Sulia Altenberg, eLearning & LMS Coordinator Minneapolis, MN *Ms. Altenberg has nothing to disclose. *Relationship Disclosure |